William Scott Durall - 28 Jan 2026 Form 4 Insider Report for CARLSMED, INC. (CARL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
30 Jan 2026, 17:24:27 UTC
Prior SEC filing
24 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leonard Greenstein, as attorney-in-fact, for William Scott Durall

Key filing fact

William Scott Durall filed Form 4 for CARLSMED, INC. (CARL) on 30 Jan 2026.

Key facts

  • This page summarizes William Scott Durall's Form 4 filing for CARLSMED, INC. (CARL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Jan 2026, 17:24.

Change

  • Previous filing in this sequence was filed on 24 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001818744 Primary reporting owner

Durall William Scott

Relationship
Chief Commercial Officer
Address
C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
Signature
/s/ Leonard Greenstein, as attorney-in-fact, for William Scott Durall
Signature date
30 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARL transaction

Common Stock

Award

Transaction value
$0
Shares
+44,977
Change %
Price
$0.000000
Shares after
44,977
Date
28 Jan 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .